Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92.4M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
14.8M
-
Shares change
-
-3.77M
-
Total reported value, excl. options
-
$21.5M
-
Value change
-
-$32.4M
-
Put/Call ratio
-
0.66
-
Number of buys
-
39
-
Number of sells
-
-29
-
Price
-
$1.45
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q3 2024
93 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q3 2024.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.8M shares
of 92.4M outstanding shares and own 16.05% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (7.1M shares), VANGUARD GROUP INC (1.29M shares), BlackRock, Inc. (1.09M shares), FMR LLC (634K shares), STATE STREET CORP (513K shares), GEODE CAPITAL MANAGEMENT, LLC (455K shares), Propel Bio Management, LLC (345K shares), Qube Research & Technologies Ltd (322K shares), XTX Topco Ltd (231K shares), and NORTHERN TRUST CORP (219K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.